CTLA4 and hypertensive disorder: CTLA-4 is an effective negative regulator of this response by competing with CD28 for B7 ligands, for which CTLA-4 has higher affinity and avidity (Figure 3).103 Vinh et al. reported that interruption of this costimulatory signal could inhibit the inflammatory processes that underlie hypertension and vascular pathology.